1-27 of about 27 matches for site:www.researchsquare.com outcomes
https://www.researchsquare.com/article/rs-1749502/v1
Help Center Sign In Submit a Preprint Cite Share Download PDF Article Outcomes of SARS
https://www.researchsquare.com/article/rs-1749502/v1
CoV-2 variant by week in each Health and Human Services region. Outcomes Outcomes were pre-specified
Impact of coronavirus disease 2019 (COVID-19) on the perioperative outcomes of maternal and neonatal
https://www.researchsquare.com/article/rs-4250438/v1
Impact of coronavirus disease 2019 (COVID-19) on the perioperative outcomes of maternal and
https://www.researchsquare.com/article/rs-4300936/v1
Disease profile and main outcomes of COVID 19 in a population with nephrologic concern
Global burden of ischemic stroke attributable to high body-mass index in 204 countries and territori
https://www.researchsquare.com/article/rs-4385787/v1
hBMI was associated with a variety of cardiovascular and cerebrovascular outcomes, although no studies were
Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID sympto
https://www.researchsquare.com/article/rs-1756189/v2
subjects to germ-free mice led to lung inflammation and worst outcomes during pulmonary infection by
The Anti-Proliferative Effects of a Frankincense Extract in a Window of Opportunity Phase Ia Clinica
https://www.researchsquare.com/article/rs-2050004/v1
surrogate marker of effectiveness based on data that shows its association with long-term outcomes [ 25 ]. With a
Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID sympto
https://www.researchsquare.com/article/rs-1756189/v2
subjects to germ-free mice led to lung inflammation and worst outcomes during pulmonary infection by
The Anti-Proliferative Effects of a Frankincense Extract in a Window of Opportunity Phase Ia Clinica
https://www.researchsquare.com/article/rs-2050004/v1
surrogate marker of effectiveness based on data that shows its association with long-term outcomes [ 25 ]. With a
https://www.researchsquare.com/article/rs-1003006/v1
suggested that the participants were not randomised appropriately, which could bias the outcomes. Secondly, a study
https://www.researchsquare.com/browse
induce epigenomic modifications providing insight into mechanisms for susceptibility to adverse reproductive outcomes Michal Elovitz, Lauren Anton
https://www.researchsquare.com/coronavirus
at Research Article posted 2024-05-31 09:35:32 Disease profile and main outcomes of COVID
https://www.researchsquare.com/blog
research results are published based on the strength or direction of their outcomes rather than the
Real-world effectiveness of molnupiravir, azvudine and paxlovid against mortality and viral clearanc
https://www.researchsquare.com/article/rs-4311124/v1
in a few individuals during the outbreak due to inventory limitations. Outcomes Outcomes of the
https://www.researchsquare.com/article/rs-5284562/v1
Lack of assessment of the effectiveness and long-term outcomes of environmental
https://www.researchsquare.com/legal/editorial
that could be perceived to impact the reporting of research outcomes in the
https://www.researchsquare.com/blog/how-to-avoid-bias-in-research
the placebo control group to underestimate outcomes. Similarly, investigators may over or underestimate outcomes if they know participants
RRM2: a crosstalk gene for COVID-19 and intervertebral disc degeneration revealed by integrated WGCN
https://www.researchsquare.com/article/rs-4244782/v1
to 20) for the automatic construction of networks .The outcomes were examined by using
Trends and patterns of ICU referrals in the Kingdom of Saudi Arabia during the COVID- 19 pandemic: R
https://www.researchsquare.com/article/rs-4295214/v1
supply and demand of ICU capacity has significant negative impacts on patient outcomes as well as on
Covid-19 Vaccination Uptake Among Remote Communities in Malaysia: A Cross-sectional Study | Research
https://www.researchsquare.com/article/rs-4312480/v1
6 Vulnerability to infection and a propensity for severe outcomes, such as acute respiratory
https://www.researchsquare.com/research-quality-evaluation
PRNewswire article . Full Clarivate report .) Our goal is to accelerate peer review, thus improving outcomes for authors
Real-World Experience of Treatment With Thrombopoietin Receptor Agonists in Anti-thymocyte Globulin-
https://www.researchsquare.com/article/rs-953779/v1
mellitus, n = 2; chronic renal failure, n = 2; invasive aspergillus infection, n = 1. 3.2 Clinical outcomes Initially, all patients received
The digital witness: Exploring gestural misinformation in tele-forensic interviews with 5-8-year-old
https://www.researchsquare.com/article/rs-4311500/v1
relevant information provided in the tele-FI condition. Age did not affect interview outcomes. This study provides further
Real-World Experience of Treatment With Thrombopoietin Receptor Agonists in Anti-thymocyte Globulin-
https://www.researchsquare.com/article/rs-953779/v1
mellitus, n = 2; chronic renal failure, n = 2; invasive aspergillus infection, n = 1. 3.2 Clinical outcomes Initially, all patients received
QuantiFERON SARS-CoV-2 assay for the evaluation of cellular immunity after immunization with mRNA SA
https://www.researchsquare.com/article/rs-4308184/v1
secreting T-cells has been associated with a milder disease course, while severe clinical outcomes have been associated with
https://www.researchsquare.com/article/rs-3552451/v1
on the participating components, which results in five types of outcomes of pairwise
Assessment of the Efficacy and Safety of Baricitinib Treatment in COVID-19 Patients: a real-world st
https://www.researchsquare.com/article/rs-4418170/v1
For example, IL-6 receptor antagonists like tocilizumab have shown potential to enhance clinical outcomes in critical